BlackRock Global Funds (“BGF”)–Shareholder Notice-Singapore

Shareholder Notification BlackRock Global Funds would like to provide you with the attached updated BGF SG Prospectus and Product Highlights Sheets booklet, both issued on 13 May 2024.  

Neuberger Berman Investment Funds plc – Updated Prospectus (Recognised Schemes)

Shareholder Notice The Fund Manager wishes to inform you that they have updated the Prospectus of Neuberger Berman Investment Funds plc. with the insertion of a shareholder notice issued recently to notify shareholders of some key changes to NBIF and its sub-funds, which will be reflected in the revised prospectus and supplements. For more details, please refer to the shareholder notice and Prospectus.  

Neuberger Berman Investment Funds plc – Shareholder Notice – 2024 Mid-Year update (SG)

Shareholder Notice The Fund Manager wishes to notify shareholders of some key changes to NBIF and its sub-funds, which will be reflected in the revised prospectus and supplements. For more details, please refer to the shareholder notice.  

Schroder International Selection Fund prospectus has been registered

Shareholder notification The fund manager wishes to inform you that the Schroder International Selection Fund prospectus has been registered. For more details, please read the shareholder notification letter.

Eastspring Investments – Recognised SG SICAV Prospectus & PHS (Effective 2 May 2024)

Shareholder Notice Eastspring Investments (Singapore) Limited would like to inform you of an update to the SG SICAV Prospectus and updated PHS (booklet & individual) effective on 2nd May 2024. For more details, please refer to the Prospectus and Product Highlight Sheet.  

Investor Notice – Nikko AM All China Equity Fund – Termination of the Fund

Shareholder Notification

Please be advised that the managers of the Fund would like to inform you of their intention to terminate the Fund with effect from 6 June 2024 or such later date as shall be notified to you in writing (the “Termination Date”). 

  Please refer to the notice letter here.  

Fidelity Funds – First Replacement Singapore Prospectus

Shareholder Notification The fund manager would like to inform you that the First Supplementary Singapore Prospectus of the Fidelity Funds SICAV and the PHSes of FF-Absolute Return Multi Strategy Fund and FF-Global Equity Income Fund have been registered with the MAS effective 30 April. Please refer to the Singapore Prospectus, Absolute Return Multi Strategy Fund Product Highlight Sheet, and Global Equity Income Fund Product Highlight Sheet.

Fullerton Lux Funds – Singapore Prospectus update

Shareholder Notice The fund manager would like to inform you of an update to the Fullerton Lux Funds Prospectus. Please refer to the attached Prospectus for more details.

Manulife Funds – Prospectus and Product Highlights Sheet (April 2024)

The fund manager would like to share the updated Prospectus of Manulife Funds, which takes immediate effect and supersede all previous versions. Please refer to the updated Prospectus.

Manulife Global Fund – Singapore Replacement Prospectus & Product Highlights Sheet (29 Apr 2024)

The fund manager would like to share the latest Manulife Global Fund (MGF) Singapore Replacement Prospectus and Product Highlights Sheet dated 29 April 2024. These documents supersede all previous versions.
  1. MGF Singapore Replacement Prospectus dated 29 April 2024
  2. Product Highlight Sheet dated 29 April 2024 for:
 

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com